Biotech · Private company
AMAG Pharmaceuticals, Inc.
Track this companyFree. Adds AMAG Pharmaceuticals, Inc. to your Dealase workspace and tells you when its record changes.
Clinical trials253 recruiting or active
Pipeline programs22From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline22
- AMAG-423 (digoxin immune fab)Phase 3 · Severe PreeclampsiaClinicalTrials.gov · fetched Nov 12, 2026
- FCMPhase 3 · Iron Deficiency AnemiaClinicalTrials.gov · fetched Nov 12, 2026
- ferumoxytolPhase 3 · Iron Deficiency AnemiaClinicalTrials.gov · fetched Nov 12, 2026
- FerumoxytolPhase 3 · Chronic Kidney Disease; Iron Deficiency AnemiaClinicalTrials.gov · fetched Nov 12, 2026
- ferumoxytol or oral ironPhase 3 · AnemiaClinicalTrials.gov · fetched Nov 12, 2026
- Hydroxyprogesterone Caproate Injection (HPC), 250mg/mLPhase 3 · Preterm BirthClinicalTrials.gov · fetched Nov 12, 2026
- Iron sucrosePhase 3 · Chronic Kidney Disease; Iron Deficiency AnemiaClinicalTrials.gov · fetched Nov 12, 2026
- Iron sucrosePhase 3 · Iron Deficiency AnemiaClinicalTrials.gov · fetched Nov 12, 2026
- Makena® (Hydroxyprogesterone Caproate Injection, 250 mg/mL)Phase 3 · Assessing Injection Pain of Makena® (Hydroxyprogesterone Caproate Injection, 250 mg/mL) in Healthy Post-menopausal WomenClinicalTrials.gov · fetched Nov 12, 2026
- Oral IronPhase 3 · Iron Deficiency AnemiaClinicalTrials.gov · fetched Nov 12, 2026
- VehiclePhase 3 · Preterm BirthClinicalTrials.gov · fetched Nov 12, 2026
- CiraparantagPhase 2 · HealthyClinicalTrials.gov · fetched Nov 12, 2026
- ferumoxytolPhase 2 · Peripheral Arterial Disease (PAD)ClinicalTrials.gov · fetched Nov 12, 2026
- FerumoxytolPhase 2 · Iron DeficiencyClinicalTrials.gov · fetched Nov 12, 2026
- Iron SucrosePhase 2 · Iron DeficiencyClinicalTrials.gov · fetched Nov 12, 2026
- Point-of-Care Coagulometer (investigational device)Phase 2 · HealthyClinicalTrials.gov · fetched Nov 12, 2026
- ferumoxytolPhase 1 · AnemiaClinicalTrials.gov · fetched Nov 12, 2026
- Makena® (Hydroxyprogesterone Caproate Injection, 250 mg/mL)Phase 1 · Comparing Bioavailability When Makena® is Administered in Healthy Post-menopausal WomenClinicalTrials.gov · fetched Nov 12, 2026
- moxifloxacinPhase 1 · AnemiaClinicalTrials.gov · fetched Nov 12, 2026
- ASQ-3, Bayley III, Neurologic examChildren Whose Mothers Received 17P and Those Who Received Vehicle in the 17P Efficacy TrialClinicalTrials.gov · fetched Nov 12, 2026
- FerumoxytolIron Deficiency Anemia TreatmentClinicalTrials.gov · fetched Nov 12, 2026
- Iron SucroseIron Deficiency Anemia TreatmentClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials25
- Study of Ciraparantag for Reversal of Anticoagulation Induced by Edoxaban, Apixaban or Rivaroxaban in Healthy AdultsPHASE2 · TERMINATED · started Oct 13, 2021ClinicalTrials.gov NCT04593784 · fetched Nov 12, 2026
- Vaginal Dehydroepiandrosterone (DHEA) in Postmenopausal Breast Cancer Survivors on Aromatase InhibitorsPHASE2 · TERMINATED · started Jun 7, 2021ClinicalTrials.gov NCT04493333 · fetched Nov 12, 2026
- 17-OHPC in Pregnancy: IM vs SC RoutesTERMINATED · started Jun 16, 2020ClinicalTrials.gov NCT04183452 · fetched Nov 12, 2026
- Trial of IV vs Oral Iron Treatment of Iron Deficiency Anemia in the Post-Operative Bariatric Surgical PatientPHASE3 · RECRUITING · started Feb 27, 2020ClinicalTrials.gov NCT04268849 · fetched Nov 12, 2026
- IV Iron vs Oral Iron for Treatment of Anemia in Women With Abnormal Uterine BleedingPHASE4 · UNKNOWN · started Feb 14, 2020ClinicalTrials.gov NCT04205266 · fetched Nov 12, 2026
- A Study to Evaluate Ferumoxytol for the Treatment of Iron Deficiency Anemia (IDA) in Pediatric SubjectsPHASE3 · RECRUITING · started Sep 18, 2019ClinicalTrials.gov NCT03893045 · fetched Nov 12, 2026
- Intravenous Infusions of Ferumoxytol Compared to Oral Ferrous Sulfate for the Treatment of Anemia in PregnancyPHASE3 · COMPLETED · started Dec 17, 2018ClinicalTrials.gov NCT03657433 · fetched Nov 12, 2026
- A Study to Evaluate the Safety (Compared to Iron Sucrose), Efficacy and Pharmacokinetics of Ferumoxytol for the Treatment of Iron Deficiency Anemia (IDA) in Pediatric Subjects With Chronic Kidney Disease (CKD)PHASE3 · RECRUITING · started Aug 13, 2018ClinicalTrials.gov NCT03619850 · fetched Nov 12, 2026
- Study of the Efficacy and Safety of AMAG-423 (Digoxin Immune Fab) in Antepartum Subjects With Severe PreeclampsiaPHASE2_PHASE3 · TERMINATED · started Apr 12, 2017ClinicalTrials.gov NCT03008616 · fetched Nov 12, 2026
- Study Assessing Injection Pain of Makena® (Hydroxyprogesterone Caproate Injection, 250 mg/mL) When Administered Via Subcutaneous Auto-injector vs Intramuscular Injection Via Needle and Syringe in Healthy Post-menopausal WomenPHASE3 · TERMINATED · started Oct 7, 2016ClinicalTrials.gov NCT02937766 · fetched Nov 12, 2026
- Comparing Bioavailability When Preservative-free Makena® (Hydroxyprogesterone Caproate Injection, 250 mg/mL) is Administered as an Intramuscular Manual Injection or as a Subcutaneous Injection Using an Auto-injector in Healthy Post-menopausal WomenPHASE1 · COMPLETED · started Sep 1, 2016ClinicalTrials.gov NCT02940522 · fetched Nov 12, 2026
- A Phase III Safety Study of Ferumoxytol Compared to Ferric Carboxymaltose for the Treatment of Iron Deficiency Anemia (IDA)PHASE3 · COMPLETED · started Feb 29, 2016ClinicalTrials.gov NCT02694978 · fetched Nov 12, 2026
- Pilot Study: Randomized, Placebo-controlled Comparator Trial of IV vs Oral Iron Treatment of RLS With IDA. (IVOR-IDA)PHASE2 · COMPLETED · started Aug 1, 2014ClinicalTrials.gov NCT02499354 · fetched Nov 12, 2026
- Compare Efficacy/Safety of Repeat Doses of Ferumoxytol With Iron Sucrose in CKD Subjects With IDA and on HemodialysisPHASE4 · COMPLETED · started Aug 1, 2013ClinicalTrials.gov NCT01227616 · fetched Nov 12, 2026
- A Trial of Ferumoxytol for the Episodic Treatment of Iron Deficiency Anemia in Pediatric Participants With Chronic Kidney DiseasePHASE3 · TERMINATED · started Dec 27, 2011ClinicalTrials.gov NCT01264679 · fetched Nov 12, 2026
- A Trial of Ferumoxytol for the Treatment of Iron Deficiency Anemia in Pediatric Participants With Nondialysis-Dependent Chronic Kidney DiseasePHASE3 · TERMINATED · started Oct 17, 2011ClinicalTrials.gov NCT01155388 · fetched Nov 12, 2026
- Total Dose Infusion of Ferumoxytol(1020mg) in 15 Minutes for Iron Deficiency AnemiaNA · COMPLETED · started Jun 1, 2011ClinicalTrials.gov NCT01374919 · fetched Nov 12, 2026
- A Prospective, Noninterventional Follow-Up Study of Children Aged 23 to 25 Months, Born to Mothers Who Received Hydroxyprogesterone Caproate Injection, 250 mg/mL, or Vehicle for Prevention of Preterm BirthCOMPLETED · started Nov 9, 2010ClinicalTrials.gov NCT01146990 · fetched Nov 12, 2026
- A Trial of Ferumoxytol for the Episodic Treatment of Iron Deficiency AnemiaPHASE3 · COMPLETED · started Jul 27, 2010ClinicalTrials.gov NCT01114217 · fetched Nov 12, 2026
- A Trial Comparing Ferumoxytol With Placebo for the Treatment of Iron Deficiency AnemiaPHASE3 · COMPLETED · started Jun 19, 2010ClinicalTrials.gov NCT01114139 · fetched Nov 12, 2026
- A Trial Comparing Ferumoxytol to Iron Sucrose for the Treatment of Iron Deficiency Anemia in Adult Subjects With Chronic Kidney DiseasePHASE2 · COMPLETED · started Mar 1, 2010ClinicalTrials.gov NCT01052779 · fetched Nov 12, 2026
- Confirmatory Study of 17P vs Vehicle for Prevention of Preterm Birth in Women w/ Previous Spontaneous Preterm DeliveryPHASE3 · COMPLETED · started Oct 1, 2009ClinicalTrials.gov NCT01004029 · fetched Nov 12, 2026
- Magnetic Resonance Angiography for Peripheral Arterial Disease (PAD)PHASE2 · COMPLETED · started Sep 1, 2008ClinicalTrials.gov NCT00707876 · fetched Nov 12, 2026
- A Study of the Electrocardiogram Effects and Pharmacokinetics of Ferumoxytol in Healthy Men and WomenPHASE1 · COMPLETED · started May 1, 2006ClinicalTrials.gov NCT00360425 · fetched Nov 12, 2026
- Ferumoxytol Versus Oral Iron in the Treatment of Anemia in Hemodialysis PatientsPHASE3 · COMPLETED · started Aug 1, 2004ClinicalTrials.gov NCT00233597 · fetched Nov 12, 2026